Search Results

Search Results for

S2001

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

Continue Reading »
A021806

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Continue Reading »
D-US-60010-001

A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment (NAPOLI 3)

Continue Reading »
EA2186

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

Continue Reading »
ES2018-01 (Suspended)

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (Suspended)

Continue Reading »
EA2161-Suspended

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery-Suspended

Continue Reading »

Search Again